Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
Key Points Weak stocks despite improving fundamentals: Chemical shares declined 15.0% in Q3’26 despite higher y/y prices and margins Earnings recovery largely reflected in consensus: Integrated PE margins rose ~16% ......
Key Points Conflict-related volume disruption and weaker polymer pricing cloud Q3 earnings Fertilizer pricing offers relative resilience, with ammonia and urea up 30% and 14% sequentially Over the next 12-months, ......
Key Points We’re updating our forecast for BWXT post attending the firm’s investor conference earlier this week in New York. The firm reiterated all aspects of 2026 financial guidance and ......
Key Points Capex falls from >USD5bn toward USD2.0–2.5bn, with spending shifting back to core industrial gases ~400bps of ROC drag should unwind as projects start contributing, with electronics adding growth ......
Key Points Ironton reliability improvements, 12,000 lbs./hour demonstrated production and on-site compounding position PCT for the next phase of the ramp P&G validation, 69 active trials, and regulatory mandates provide ......
Key Points Cost cuts, reliability, footprint optimization and ACI alone bridge Westlake toward ~USD1.8bn of run-rate EBITDA—before a meaningful housing recovery Shares sit 56% below their 2024 peak despite resilient ......